In the coronavirus efficacy (COVE) phase 3 clinical trial, vaccine recipients were assessed
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …

Measuring immune correlates of disease acquisition and protection in the context of a clinical
trial is a prerequisite for improved vaccine design. We analysed binding and neutralizing …

In the PREVENT-19 phase 3 trial of the NVX-CoV2373 vaccine (NCT04611802), anti-spike
binding IgG concentration (spike IgG), anti-RBD binding IgG concentration (RBD IgG), and …

MUC1 protein is an attractive target for anticancer drug delivery owing to its overexpression
in most adenocarcinomas. In this study, a reported MUC1 protein aptamer is exploited as the …

The best assay or marker to define mRNA-1273 vaccine–induced antibodies as a correlate
of protection (CoP) is unclear. In the COVE trial, participants received two doses of the mRNA…

Real-time sensing and modeling of the human body, especially the hands, is an important
research endeavor for various applicative purposes such as in natural human computer …

Background Modest efficacy was reported for the HIV vaccine tested in the RV144 trial, which
comprised a canarypox vector (ALVAC) and envelope (env) glycoprotein (gp120). These …

In the phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine conducted in the US, Chile,
and Peru, anti-spike binding IgG concentration (spike IgG) and pseudovirus 50% …

State of charge (SOC) estimation is one of the important tasks of battery management system
(BMS). Being different from other researches, a novel method of SOC estimation for pouch …

Quantification of the active site number and the site-specific turnover frequency (TOF) of
nanoscale electrocatalysts is the prerequisite for understanding their intrinsic catalytic properties…